Yuichiro� Doki

Osaka Gakuin University (JP)

Research Areas

Discover Papers by Yuichiro� Doki

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

102

Publications

2278

Citations

50714

i10-index

921

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Nivolumab versus chemotherapy in patients with adv...	2019	1195
Two FOXP3+CD4+ T cell subpopulations distinctly co...	2016	861
Reprogramming of Mouse and Human Cells to Pluripot...	2011	751
CD13 is a therapeutic target in human liver cancer...	2010	602
Esophageal cancer practice guidelines 2017 edited ...	2018	585
Nivolumab Combination Therapy in Advanced Esophage...	2022	532
Esophageal cancer practice guidelines 2017 edited ...	2018	524
Exosomal microRNA in serum is a novel biomarker of...	2015	481
Guidelines for Diagnosis and Treatment of Carcinom...	2014	454
Thoracic and cardiovascular surgery in Japan durin...	2016	398

Publications

1.
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
Year: 2019Citations: 1195DOI: 10.1016/s1470-2045(19)30626-6
2.
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Year: 2016Citations: 861DOI: 10.1038/nm.4086
3.
Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs
Year: 2011Citations: 751DOI: 10.1016/j.stem.2011.05.001
4.
CD13 is a therapeutic target in human liver cancer stem cells
Year: 2010Citations: 602DOI: 10.1172/jci42550
5.
Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
Year: 2018Citations: 585DOI: 10.1007/s10388-018-0642-8
6.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Year: 2022Citations: 532
7.
Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Year: 2018Citations: 524DOI: 10.1007/s10388-018-0641-9
8.
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
Year: 2015Citations: 481DOI: 10.1038/bjc.2015.201
9.
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
Year: 2014Citations: 454DOI: 10.1007/s10388-014-0465-1
10.
Thoracic and cardiovascular surgery in Japan during 2014
Year: 2016Citations: 398DOI: 10.1007/s11748-016-0695-3

About Yuichiro� Doki

Yuichiro� Doki is a researcher with 2278 publications and 50714 citations. They are affiliated with Osaka Gakuin University. Their research focuses on . With an h-index of 102, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Yuichiro� Doki and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year